This Article  • Full text  • PDF  • Glossary  • Financial Disclosures  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (503)  • Contact me when this article is cited  Related Content  • Related letters  • Related articles  • Similar articles in JAMA  Topic Collections  • Evidence-Based Medicine  • Papillomavirus, Human  • Gynecology  • Women's Health, Other  • Alert me on articles by topic

Thomas C. Wright, Jr, MD; J. Thomas Cox, MD; L. Stewart Massad, MD; Leo B. Twiggs, MD; Edward J. Wilkinson, MD; for the 2001 ASCCP-Sponsored Consensus Conference

JAMA. 2002;287:2120-2129.

Objective  To provide evidence-based consensus guidelines for the management of women with cervical cytological abnormalities and cervical cancer precursors.

Participants  A panel of 121 experts in the diagnosis and management of cervical cancer precursors, including representatives from 29 professional organizations, federal agencies, and national and international health organizations, were invited to participate in a consensus conference sponsored by the American Society for Colposcopy and Cervical Pathology (ASCCP).

Evidence and Consensus Process  Guidelines for the management of women with cervical cytological abnormalities were developed through a multistep process. Starting 6 months before the conference, working groups developed draft management guidelines based on formal literature reviews of English-language articles published in 1988-2001, as well as input from the professional community at large, obtained using interactive Internet-based bulletin boards. On September 6-8, 2001, the ASCCP Consensus Conference was held in Bethesda, Md. Guidelines with supporting evidence were presented and underwent discussion, revision, and voting.

Conclusions  Management of women with atypical squamous cells (ASC) depends on whether the Papanicolaou test is subcategorized as of undetermined significance (ASC-US) or as cannot exclude high-grade squamous intraepithelial lesion (HSIL) (ASC-H). Women with ASC-US should be managed using a program of 2 repeat cytology tests, immediate colposcopy, or DNA testing for high-risk types of human papillomavirus (HPV). Testing for HPV DNA is the preferred approach when liquid-based cytology is used for screening. In most instances, women with ASC-H, low-grade squamous intraepithelial lesion, HSIL, and atypical glandular cells should be referred for immediate colposcopic evaluation.

Author Affiliations: Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, NY (Dr Wright); Student Health Services, University of California–Santa Barbara, and American Social Health Association, Durham, NC (Dr Cox); Department of Obstetrics and Gynecology, Cook County Hospital, Chicago, Ill (Dr Massad); Institute of Women's Health, University of Miami, Miami, Fla (Dr Twiggs); and Department of Pathology, University of Florida College of Medicine, Gainesville (Dr Wilkinson).

RELATED LETTERS

Cost-effectiveness of Alternative Triage Strategies for Atypical Squamous Cells of Undetermined Significance
Jane J. Kim, Thomas C. Wright, and Sue J. Goldie
JAMA. 2002;287(18):2382-2390.
ABSTRACT | FULL TEXT  

Testing for Human Papillomavirus in Women With Abnormal Pap Smear Results
Kirsten J. McCaffery, Jo Waller, Sue Forrest, Jane Wardle, George F. Sawaya, Karen Smith-McCune, Thomas C. Wright, Jr, J. Thomas Cox, L. Stewart Massad, Leo B. Twiggs, and Edward J. Wilkinson
JAMA. 2002;288(11):1350.
EXTRACT | FULL TEXT  

RELATED ARTICLES

The 2001 Bethesda System: Terminology for Reporting Results of Cervical Cytology
Diane Solomon, Diane Davey, Robert Kurman, Ann Moriarty, Dennis O'Connor, Marianne Prey, Stephen Raab, Mark Sherman, David Wilbur, Thomas Wright, Jr, Nancy Young, and for the Forum Group Members and the Bethesda 2001 Workshop
JAMA. 2002;287(16):2114-2119.
ABSTRACT | FULL TEXT  

New Bethesda Terminology and Evidence-Based Management Guidelines for Cervical Cytology Findings
Mark H. Stoler
JAMA. 2002;287(16):2140-2141.
EXTRACT | FULL TEXT  

April 24, 2002
JAMA. 2002;287(16):2153-2154.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis
Arbyn et al.
BMJ 2008;337:a1284-a1284.
ABSTRACT | FULL TEXT  

Urogenital atrophy
Pitkin et al.
Menopause Int 2008;14:136-137.
ABSTRACT | FULL TEXT  

Factors Influencing Histologic Confirmation of High-Grade Squamous Intraepithelial Lesion Cytology
Castle et al.
Obstet Gynecol 2008;112:637-645.
ABSTRACT | FULL TEXT  

Health and Economic Implications of HPV Vaccination in the United States
Kim and Goldie
NEJM 2008;359:821-832.
ABSTRACT | FULL TEXT  

The Prevalence of High-Risk Human Papillomavirus in Women with Different Types of Cervical Cancer
Datta and Weinstock
ANN INTERN MED 2008;149:283-283.
FULL TEXT  

Cervical Intraepithelial Neoplasia Grade 2 or Worse in Human Immunodeficiency Virus-Infected Women With Mildly Abnormal Cervical Cytology
Boardman et al.
Obstet Gynecol 2008;112:238-243.
ABSTRACT | FULL TEXT  

Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-Analysis
Koshiol et al.
Am J Epidemiol 2008;168:123-137.
ABSTRACT | FULL TEXT  

Comparison of the Third Wave Invader Human Papillomavirus (HPV) Assay and the Digene HPV Hybrid Capture 2 Assay for Detection of High-Risk HPV DNA
Ginocchio et al.
J. Clin. Microbiol. 2008;46:1641-1646.
ABSTRACT | FULL TEXT  

HPV and Cervical Cancer Testing and Prevention: Knowledge, Beliefs, and Attitudes Among Hispanic Women
Vanslyke et al.
Qual Health Res 2008;18:584-596.
ABSTRACT  

Role of age stratification for colposcopy referral following initial diagnosis of mild dyskaryosis
Crowther et al.
J. Clin. Pathol. 2008;61:665-668.
ABSTRACT | FULL TEXT  

Biological behavior of CIN lesions is predictable by multiple parameter logistic regression models
van Hamont et al.
Carcinogenesis 2008;29:840-845.
ABSTRACT | FULL TEXT  

Adding Human Papillomavirus Testing to Cytology for Primary Cervical Cancer Screening: Shooting First and Asking Questions Later
Sawaya
ANN INTERN MED 2008;148:557-559.
FULL TEXT  

Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination
Goldhaber-Fiebert et al.
JNCI J Natl Cancer Inst 2008;100:308-320.
ABSTRACT | FULL TEXT  

A retrospective clinical study of the treatment of high-grade anal dysplasia by infrared coagulation in a population of HIV-positive men who have sex with men
Cranston et al.
Int J STD AIDS 2008;19:118-120.
ABSTRACT | FULL TEXT  

Detection of High-Risk Papillomavirus DNA with Commercial Invader-Technology-Based Analyte-Specific Reagents following Automated Extraction of DNA from Cervical Brushings in ThinPrep Media
Schutzbank et al.
J. Clin. Microbiol. 2007;45:4067-4069.
ABSTRACT | FULL TEXT  

Human Papillomavirus Infections in Primary Care
Ogunmodede et al.
Clin Med Res 2007;5:210-217.
ABSTRACT | FULL TEXT  

Trials That Matter: Liquid-Based Cervical Cytology: Disadvantages Seem to Outweigh Advantages
Sawaya and Sox
ANN INTERN MED 2007;147:668-669.
FULL TEXT  

Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer
Mayrand et al.
NEJM 2007;357:1579-1588.
ABSTRACT | FULL TEXT  

HPV Vaccines Prophylactic, Not Therapeutic
Markowitz
JAMA 2007;298:805-806.
FULL TEXT  

Diagnostic Utility of Endocervical Curettage in Women Undergoing Colposcopy for Equivocal or Low-Grade Cytologic Abnormalities
Solomon et al.
Obstet Gynecol 2007;110:288-295.
ABSTRACT | FULL TEXT  

Risk of Precancer and Follow-up Management Strategies for Women With Human Papillomavirus-Negative Atypical Squamous Cells of Undetermined Significance
Safaeian et al.
Obstet Gynecol 2007;109:1325-1331.
ABSTRACT | FULL TEXT  

Adherence to Recommendations for Follow-up to Abnormal Pap Tests
Eggleston et al.
Obstet Gynecol 2007;109:1332-1341.
ABSTRACT | FULL TEXT  

Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
The FUTURE II Study Group
NEJM 2007;356:1915-1927.
ABSTRACT | FULL TEXT  

HPV Vaccination -- More Answers, More Questions
Sawaya and Smith-McCune
NEJM 2007;356:1991-1993.
FULL TEXT  

Encouragement of Patient Self-management and Adherence through Use of a Computerized Tracking System for Cervical and Colon Cancer Screening
Bock and Kwan
J Am Board Fam Med 2007;20:316-319.
FULL TEXT  

Cervical Cancer Screening Rates in the United States and the Potential Impact of Implementation of Screening Guidelines
Solomon et al.
CA Cancer J Clin 2007;57:105-111.
ABSTRACT | FULL TEXT  

Prospective Evaluation of the Hybrid Capture 2 and AMPLICOR Human Papillomavirus (HPV) Tests for Detection of 13 High-Risk HPV Genotypes in Atypical Squamous Cells of Uncertain Significance
Halfon et al.
J. Clin. Microbiol. 2007;45:313-316.
ABSTRACT | FULL TEXT  

What Do Women in the U.S. Know about Human Papillomavirus and Cervical Cancer?
Tiro et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:288-294.
ABSTRACT | FULL TEXT  

Follow-Up of Abnormal Pap Smears Among Incarcerated Women
Clarke et al.
JOURNAL OF CORRECTIONAL HEALTH CARE 2007;13:22-26.
ABSTRACT  

Human Papillomavirus and Prognosis of Oropharyngeal Squamous Cell Carcinoma: Implications for Clinical Research in Head and Neck Cancers
Gillison
JCO 2006;24:5623-5625.
FULL TEXT  

Cervical Intraepithelial Neoplasia in Adolescent Women: Incidence and Treatment Outcomes
Case et al.
Obstet Gynecol 2006;108:1369-1374.
ABSTRACT | FULL TEXT  

Reproductive Factors, Oral Contraceptive Use, and Human Papillomavirus Infection: Pooled Analysis of the IARC HPV Prevalence Surveys.
Vaccarella et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:2148-2153.
ABSTRACT | FULL TEXT  

Cervical Cancer Screening, Abnormal Cytology Management, and Counseling Practices in the United States
Irwin et al.
Obstet Gynecol 2006;108:397-409.
ABSTRACT | FULL TEXT  

Incidence of Cervical Cytological Abnormalities With Aging in the Women's Health Initiative: A Randomized Controlled Trial
Yasmeen et al.
Obstet Gynecol 2006;108:410-419.
ABSTRACT | FULL TEXT  

Rate of Pathology From Atypical Glandular Cell Pap Tests Classified by the Bethesda 2001 Nomenclature.
DeSimone et al.
Obstet Gynecol 2006;107:1285-1291.
ABSTRACT | FULL TEXT  

Human papillomavirus viral load: a possible marker for cervical disease in HIV-infected women
Lillo and Uberti-Foppa
J Antimicrob Chemother 2006;57:810-814.
ABSTRACT | FULL TEXT  

Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening.
Bidus et al.
Obstet Gynecol 2006;107:997-1005.
ABSTRACT | FULL TEXT  

Human papillomavirus triage for young women with atypical squamous cells of undetermined significance.
Wright et al.
Obstet Gynecol 2006;107:822-829.
ABSTRACT | FULL TEXT  

Social and psychological impact of HPV testing in cervical screening: a qualitative study.
McCaffery et al.
Sex. Transm. Infect. 2006;82:169-174.
ABSTRACT | FULL TEXT  

Managing low-grade cervical lesions.
Howlett et al.
CMAJ 2006;174:813-813.
FULL TEXT  

Managing low-grade cervical lesions.
Franco and Lau
CMAJ 2006;174:813-814.
FULL TEXT  

Epidemiology and Natural History of Genital Human Papillomavirus Infection
Weaver
JAOA: Journal of the American Osteopathic Association 2006;106:S2-S8.
ABSTRACT | FULL TEXT  

Cost-Effectiveness Analysis Based on the Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS)
Kulasingam et al.
JNCI J Natl Cancer Inst 2006;98:92-100.
ABSTRACT | FULL TEXT  

Discovery of Novel Methylation Biomarkers in Cervical Carcinoma by Global Demethylation and Microarray Analysis
Sova et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:114-123.
ABSTRACT | FULL TEXT  

Transvaginal Ultrasonography in the Prediction of Preterm Birth After Treatment for Cervical Intraepithelial Neoplasia
Crane et al.
Obstet Gynecol 2006;107:37-44.
ABSTRACT | FULL TEXT  

Screen-and-Treat Approaches for Cervical Cancer Prevention in Low-Resource Settings: A Randomized Controlled Trial
Denny et al.
JAMA 2005;294:2173-2181.
ABSTRACT | FULL TEXT  

Feasibility of Management of High-Grade Cervical Lesions in a Single Visit: A Randomized Controlled Trial
Brewster et al.
JAMA 2005;294:2182-2187.
ABSTRACT | FULL TEXT  

A 21-Year-Old Woman With Atypical Squamous Cells of Undetermined Significance
Sawaya
JAMA 2005;294:2210-2218.
FULL TEXT  

Cervical Cancer Prevention: Making Programs More Appropriate and Pragmatic
Blumenthal and Gaffikin
JAMA 2005;294:2225-2228.
FULL TEXT  

Evaluating the Risk of Cervical Precancer with a Combination of Cytologic, Virologic, and Visual Methods
Wang et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:2665-2668.
ABSTRACT | FULL TEXT  

Acceptability of human papillomavirus self testing in female adolescents
Kahn et al.
Sex. Transm. Infect. 2005;81:408-414.
ABSTRACT | FULL TEXT  

Management of low-grade cervical lesions in young women
Lau and Franco
CMAJ 2005;173:771-774.
FULL TEXT  

Cervical Cytology Screening and Evaluation
Noller
Obstet Gynecol 2005;106:391-397.
FULL TEXT  

The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice
Khan et al.
JNCI J Natl Cancer Inst 2005;97:1072-1079.
ABSTRACT | FULL TEXT  

Cervical Dysplasia in Adolescents
Wright et al.
Obstet Gynecol 2005;106:115-120.
ABSTRACT | FULL TEXT  

Cost-effectiveness of Human Papillomavirus DNA Testing in the United Kingdom, The Netherlands, France, and Italy
Kim et al.
JNCI J Natl Cancer Inst 2005;97:888-895.
ABSTRACT | FULL TEXT  

Comparison of Two Commercial Assays for Detection of Human Papillomavirus (HPV) in Cervical Scrape Specimens: Validation of the Roche AMPLICOR HPV Test as a Means To Screen for HPV Genotypes Associated with a Higher Risk of Cervical Disorders
van Ham et al.
J. Clin. Microbiol. 2005;43:2662-2667.
ABSTRACT | FULL TEXT  

Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis
Ogilvie et al.
Sex. Transm. Infect. 2005;81:207-212.
ABSTRACT | FULL TEXT  

Human Papillomavirus Genotype Distribution in Low-Grade Cervical Lesions: Comparison by Geographic Region and with Cervical Cancer
Clifford et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:1157-1164.
ABSTRACT | FULL TEXT  

Atypical Squamous Cells of Undetermined Significance: Human Papillomavirus Testing in Adolescents
Boardman et al.
Obstet Gynecol 2005;105:741-746.
ABSTRACT | FULL TEXT  

Dysplasia Associated With Atypical Glandular Cells on Cervical Cytology
Sharpless et al.
Obstet Gynecol 2005;105:494-500.
ABSTRACT | FULL TEXT  

Lack of Adherence to Practice Guidelines for Women With Atypical Glandular Cells on Cervical Cytology
Sharpless et al.
Obstet Gynecol 2005;105:501-506.
ABSTRACT | FULL TEXT  

Facile, Comprehensive, High-Throughput Genotyping of Human Genital Papillomaviruses Using Spectrally Addressable Liquid Bead Microarrays
Wallace et al.
J. Mol. Diagn. 2005;7:72-80.
ABSTRACT | FULL TEXT  

Atypical Glandular Cells in Cervical Smear During Pregnancy and Postpartum Period
Tam
Clin Med Res 2005;3:1-2.
FULL TEXT  

Atypical Papanicolaou Smear in Pregnancy
Connolly and Evans
Clin Med Res 2005;3:13-18.
ABSTRACT | FULL TEXT  

A Study of the Impact of Adding HPV Types to Cervical Cancer Screening and Triage Tests
Schiffman et al.
JNCI J Natl Cancer Inst 2005;97:147-150.
ABSTRACT | FULL TEXT  

Panel of Genes Transcriptionally Up-regulated in Squamous Cell Carcinoma of the Cervix Identified by Representational Difference Analysis, Confirmed by Macroarray, and Validated by Real-Time Quantitative Reverse Transcription-PCR
Sgarlato et al.
Clin. Chem. 2005;51:27-34.
ABSTRACT | FULL TEXT  

HPV Communication: Review of Existing Research and Recommendations for Patient Education
Anhang et al.
CA Cancer J Clin 2004;54:248-259.
ABSTRACT | FULL TEXT  

Self-testing for human papillomavirus using a vaginal swab: placing prevention of cervical cancer in the patient's hands
Kahn
Ann Oncol 2004;15:847-849.
FULL TEXT  

Cervical cancer mortality by neighbourhood income in urban Canada from 1971 to 1996
Ng et al.
CMAJ 2004;170:1545-1549.
ABSTRACT | FULL TEXT  

Treatment for Cervical Intraepithelial Neoplasia and Risk of Preterm Delivery
Sadler et al.
JAMA 2004;291:2100-2106.
ABSTRACT | FULL TEXT  

Comparison of Adolescent and Young Adult Self-Collected and Clinician-Collected Samples for Human Papillomavirus
Kahn et al.
Obstet Gynecol 2004;103:952-959.
ABSTRACT | FULL TEXT  

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine
Goldie et al.
JNCI J Natl Cancer Inst 2004;96:604-615.
ABSTRACT | FULL TEXT  

Human Papillomavirus DNA Testing as an Adjunct in Primary Screening: Is It Prime Time?
Zahn
Obstet Gynecol 2004;103:617-618.
FULL TEXT  

Cost-Effectiveness of Human Papillomavirus DNA Testing for Cervical Cancer Screening in Women Aged 30 Years or More
Goldie et al.
Obstet Gynecol 2004;103:619-631.
ABSTRACT | FULL TEXT  

Atypical Squamous Cells of Undetermined Significance in Girls and Women
Wright et al.
Obstet Gynecol 2004;103:632-638.
ABSTRACT | FULL TEXT  

The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996
Bulk et al.
J. Clin. Pathol. 2004;57:388-393.
ABSTRACT | FULL TEXT  

Have We Resolved How To Triage Equivocal Cervical Cytology?
Solomon and Schiffman
JNCI J Natl Cancer Inst 2004;96:250-251.
FULL TEXT  

Virologic Versus Cytologic Triage of Women With Equivocal Pap Smears: A Meta-analysis of the Accuracy To Detect High-Grade Intraepithelial Neoplasia
Arbyn et al.
JNCI J Natl Cancer Inst 2004;96:280-293.
ABSTRACT | FULL TEXT  

Rebuttal by Dr Sawaya
Sawaya
Arch Intern Med 2004;164:247-248.
FULL TEXT  

Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening
Wright et al.
Obstet Gynecol 2004;103:304-309.
ABSTRACT | FULL TEXT  

Adults' Knowledge and Behaviors Related to Human Papillomavirus Infection
Holcomb et al.
J Am Board Fam Med 2004;17:26-31.
ABSTRACT | FULL TEXT  

The Quality of Community Colposcopic Practice
Benedet et al.
Obstet Gynecol 2004;103:92-100.
ABSTRACT | FULL TEXT  

Denaturing High-Performance Liquid Chromatography for Detecting and Typing Genital Human Papillomavirus
Li et al.
J. Clin. Microbiol. 2003;41:5563-5571.
ABSTRACT | FULL TEXT  

Commentary on "Human Papillomavirus Infection of the Cervix: Relative Risk Association of 15 Common Anogenital Types"
Pitkin
Obstet Gynecol 2003;102:1224-1224.
FULL TEXT  

Factors Affecting the Detection Rate of Human Papillomavirus
Harper et al.
Ann Fam Med 2003;1:221-227.
ABSTRACT | FULL TEXT  

Risk of Cervical Cancer Associated with Extending the Interval between Cervical-Cancer Screenings
Sawaya et al.
NEJM 2003;349:1501-1509.
ABSTRACT | FULL TEXT  

Case 32-2003 - A 37-Year-Old Woman with Atypical Squamous Cells on a Papanicolaou Smear
Goodman and Wilbur
NEJM 2003;349:1555-1564.
FULL TEXT  

Determinants of Human Papillomavirus Load among Women with Histological Cervical Intraepithelial Neoplasia 3: Dominant Impact of Surrounding Low-Grade Lesions
Sherman et al.
Cancer Epidemiol. Biomarkers Prev. 2003;12:1038-1044.
ABSTRACT | FULL TEXT  

Comparison between Prototype Hybrid Capture 3 and Hybrid Capture 2 Human Papillomavirus DNA Assays for Detection of High-Grade Cervical Intraepithelial Neoplasia and Cancer
Castle et al.
J. Clin. Microbiol. 2003;41:4022-4030.
ABSTRACT | FULL TEXT  

Type-Specific Testing for Human Papillomavirus
Crum
NEJM 2003;349:614-615.
FULL TEXT  

Cervical Cytology Screening Practices Among Obstetrician-Gynecologists
Noller et al.
Obstet Gynecol 2003;102:259-265.
ABSTRACT | FULL TEXT  

Awareness of human papillomavirus among women attending a well woman clinic
Waller et al.
Sex. Transm. Infect. 2003;79:320-322.
ABSTRACT | FULL TEXT  

Chapter 13: Primary Screening of Cervical Cancer With Human Papillomavirus Tests
Franco
J Natl Cancer Inst Monogr 2003;2003:89-96.
ABSTRACT | FULL TEXT  

Chapter 14: Role of Triage Testing in Cervical Cancer Screening
Solomon
J Natl Cancer Inst Monogr 2003;2003:97-101.
ABSTRACT | FULL TEXT  

Chapter 16: Prophylactic Human Papillomavirus Vaccines
Lowy and Frazer
J Natl Cancer Inst Monogr 2003;2003:111-116.
ABSTRACT | FULL TEXT  

Chapter 17: Genital Human Papillomavirus Infections--Current and Prospective Therapies
Stanley
J Natl Cancer Inst Monogr 2003;2003:117-124.
ABSTRACT | FULL TEXT